Literature DB >> 7083632

The functional and physicochemical characterization of three eosinophilotactic activities released into the circulation by cold challenge of patients with cold urticaria.

S I Wasserman, K F Austen, N A Soter.   

Abstract

The eosinophilic activity appearing in the venous effluent of the cold-induced angioedematous extremity of patients with cold urticaria has been resolved into three fractions by gel filtration and Dowex-1 chromatography. The low molecular weight activity, 300-700 mw, is highly acidic while the activity of 1000-3000 mw is composed of highly acidic and less acidic moieties. Each of the three activities has a different retention time on high pressure liquid chromatography, indicating that they represent distinct fractions which differ in size, charge, and hydrophobicity. Each fraction requires a gradient to attract eosinophils in a dose-response fashion and each deactivates eosinophils at subchemotactic concentrations. The more acidic 1000-3000 mw fractions also attract human monocytes in a chemotactic gradient at concentrations identical to those which attract human eosinophils. These three classes of eosinophil chemotactic activities and the activity for monocytes appear and disappear from the venous effluent with essentially the same time course as a distinct neutrophil chemotactic factor and histamine with cold induction of angioedema in patients with cold urticaria. The elaboration of these diverse chemoattractants in experimentally induced physical allergy provides potential pathways for mast cell-mediated infiltrative reactions.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7083632      PMCID: PMC1536434     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Chemotactic deactivation of human eosinophils by the eosinophil chemotactic factor of anaphylaxis (38527).

Authors:  S I Wasserman; D Whitmer; E J Geotzl; K F Austen
Journal:  Proc Soc Exp Biol Med       Date:  1975-01

2.  Correlates of skin test reactions to Bacillus subtilis enzyme preparations.

Authors:  J Dolovich; D C Little
Journal:  J Allergy Clin Immunol       Date:  1972-01       Impact factor: 10.793

3.  Isolation of leucocytes from human blood. Further observations. Methylcellulose, dextran, and ficoll as erythrocyteaggregating agents.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

4.  Preformed eosinophil chemotactic factor of anaphylaxis (ECF-A).

Authors:  S I Wasserman; E J Goetzl; K F Austen
Journal:  J Immunol       Date:  1974-01       Impact factor: 5.422

5.  Modification of the enzymatic isotopic assay of histamine and its application to measurement of histamine in tissues, serum and urine.

Authors:  M A Beaven; S Jacobsen; Z Horáková
Journal:  Clin Chim Acta       Date:  1972-03       Impact factor: 3.786

6.  Biochemical demonstration of the activatable esterase of the rabbit netrophil involved in the chemotactic response.

Authors:  P A Ward; E L Becker
Journal:  J Immunol       Date:  1970-11       Impact factor: 5.422

7.  The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies.

Authors:  G O Solley; G J Gleich; R E Jordon; A L Schroeter
Journal:  J Clin Invest       Date:  1976-08       Impact factor: 14.808

8.  Cold urticaria: release into the circulation of histamine and eosinophil chemotactic factor of anaphylaxis during cold challenge.

Authors:  N A Soter; S I Wasserman; K F Austen
Journal:  N Engl J Med       Date:  1976-03-25       Impact factor: 91.245

9.  In vivo studies of mediator release in cold urticaria and cholinergic urticaria.

Authors:  A P Kaplan; L Gray; R E Shaff; Z Horakova; M A Beaven
Journal:  J Allergy Clin Immunol       Date:  1975-06       Impact factor: 10.793

10.  An eosinophil leukocyte chemotactic factor of anaphylaxis.

Authors:  A B Kay; D J Stechschulte; K F Austen
Journal:  J Exp Med       Date:  1971-03-01       Impact factor: 14.307

View more
  4 in total

Review 1.  Chemotactic mediators.

Authors:  P C Atkins; S I Wasserman
Journal:  Clin Rev Allergy       Date:  1983-09

2.  The urticarias. Current concepts in pathogenesis and treatment.

Authors:  K P Mathews
Journal:  Drugs       Date:  1985-12       Impact factor: 9.546

Review 3.  Mast cells in allergic diseases and mastocytosis.

Authors:  D L Marquardt; S I Wasserman
Journal:  West J Med       Date:  1982-09

Review 4.  Late asthmatic responses: inquiry into mechanisms and significance.

Authors:  W J Metzger; G W Hunninghake; H B Richerson
Journal:  Clin Rev Allergy       Date:  1985-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.